Skip to main content
. 2024 Apr 25;21(6):2838–2853. doi: 10.1021/acs.molpharmaceut.4c00008

Figure 1.

Figure 1

(a) Structural formula of LVX in its neutral and zwitterionic forms and (b) interconversion pathways of LVX to hydrates (open symbol), amorphous (filled symbol), and anhydrous/dehydrated forms (striped symbol).39,42 The broken line and gray symbol indicate a new pathway to amorphous LVX discovered in this work.